Log In
Print
BCIQ
Print
Print this Print this
 

ATSP-9172

  Manage Alerts
Collapse Summary General Information
Company Aileron Therapeutics Inc.
DescriptionStapled peptide inhibitor of hypoxia-inducible factor 1 alpha (HIF1A; HIF1-alpha)
Molecular Target Hypoxia-inducible factor 1 alpha (HIF1A) (HIF1-alpha)
Mechanism of ActionHypoxia-inducible factor 1 (HIF1) inhibitor
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationProstate cancer
Indication DetailsTreat prostate cancer
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today